Login to Your Account



Gan & Lee planning $227M IPO in China; funds for innovation, global expansion

By Pearl Liu and Bonnie Wang
Staff Writers

Tuesday, June 14, 2016

HONG KONG – Three years after a failed attempt, Chinese insulin maker Gan & Lee Pharmaceuticals Ltd. is looking at China's stock markets.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription